Hyperphosphorylation of tau is a key pathological feature in Alzheimer’s disease (AD), and studies have established the critical role of MARK4 in this event (Annadurai et al., 2017). Here, MARK4 is linked to early-onset autosomal dominant Alzheimer disease.